miR-149-3p and Lung Cancer: Enhancing Sensitivity to Cisplatin
Author Information
Author(s): Qin Beibei, Tang Dongfang, Zhang Mingzhi
Primary Institution: The First Affiliated Hospital of Zhengzhou University
Hypothesis
miR-149-3p enhances the sensitivity of lung cancer cells to cisplatin by targeting TMPRSS4.
Conclusion
Overexpression of miR-149-3p inhibits lung cancer progression and increases the responsiveness of cancer cells to cisplatin.
Supporting Evidence
- miR-149-3p levels were significantly lower in lung cancer tissues compared to adjacent normal tissues.
- Overexpression of miR-149-3p inhibited cell proliferation and promoted apoptosis in lung cancer cells.
- TMPRSS4 was identified as a target of miR-149-3p, and its overexpression reduced the sensitivity of lung cancer cells to cisplatin.
- Animal studies showed that miR-149-3p overexpression reduced tumor size and enhanced chemosensitivity.
Takeaway
This study shows that a tiny molecule called miR-149-3p can help lung cancer cells respond better to a medicine called cisplatin, which is used to treat cancer.
Methodology
The study involved analyzing miR-149-3p levels in lung cancer tissues and cells, creating DDP-resistant cell lines, and using various assays to assess cell behavior and tumor growth in mice.
Limitations
The study primarily focuses on the role of miR-149-3p in lung cancer and does not explore other potential factors influencing DDP resistance.
Participant Demographics
All participants were treatment-naive lung cancer patients aged 18 and older.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website